Real-time enrollment status for this pancreatic ductal adenocarcinoma (pdac) clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 8:36 PM UTC
| NCT Number | NCT06182072 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Ductal Adenocarcinoma (PDAC) |
| Phase | PHASE1 |
| Target Enrollment | 46 participants |
| Active Locations | 1 sites in the US |
| Sponsor | ProDa BioTech, LLC |
| Last Updated on CT.gov | October 1, 2025 (Oct 1, 2025) |
As of July 20, 2026: Clinical trial NCT06182072 is currently recruiting participants. This phase1 study for pancreatic ductal adenocarcinoma (pdac) is actively seeking new participants at 1 location across the United States. The study is sponsored by ProDa BioTech, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06182072 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06182072 was last updated Oct 1, 2025 (October 1, 2025). HelloStudys verifies this status automatically.